Colchicine to Weather the Cytokine Storm in Hospitalized Patients with COVID-19

The repurposing of colchicine for the treatment of COVID-19 was suggested based in its immunomodulatory, anti-inflammatory, and anti-viral properties. We performed a single-center propensity score matched cohort study, including all consecutive COVID-19 patients admitted to a community hospital betw...

Descripción completa

Detalles Bibliográficos
Autores principales: Brunetti, Luigi, Diawara, Oumou, Tsai, Andrew, Firestein, Bonnie L., Nahass, Ronald G., Poiani, George, Schlesinger, Naomi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565543/
https://www.ncbi.nlm.nih.gov/pubmed/32937800
http://dx.doi.org/10.3390/jcm9092961

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565543/
https://www.ncbi.nlm.nih.gov/pubmed/32937800
http://dx.doi.org/10.3390/jcm9092961

Ejemplares similares